Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$58.5K
10.83K shares
What this filing means
BRADY JAMES ALOYSIUS plans to sell 10.83K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $58.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/30/2026ACC: 0001950047-26-003075
Director
Since Mar 2025
10.83K
Shares to sell
$58.5K
Approx. market value
10.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/28/2026
10.83KTotal acquired10.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/28/2026 | Restricted Stock Units N/A | 10.83K | — |
| Total | 10.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.83K
Market value
$58.5K
3/30/2026
Total
Units
10.83K
Value
$58.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/30/2026 | 10.83K | $58.5K | NASDAQ | Planned |
| Total | 10.83K | $58.5K | ||